Medical Dictionary for Regulatory Activities (MedDRA) Update
|
|
|
- Bennett Robbins
- 9 years ago
- Views:
Transcription
1 Medical Dictionary for Regulatory Activities (MedDRA) Update International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
2 Topics MedDRA as an ICH initiative How MedDRA is used Standardised MedDRA Queries (SMQs) Recent developments MedDRA and Vigibase Chinese MedDRA Translation CTCAE Developments Medical Device Terms Developments MedDRA Free Training
3 Objectives for MedDRA Development Result of an ICH initiative (M1) An international multi-lingual terminology Standardized communication between industry and regulators Support of electronic submissions Application through all phases of the development cycle Classification a wide range of clinical information for multiple medical product areas Maintained by MSSO
4 Maintenance Organization Structure User Group Management Board Board of Directors Staff ICH Steering Committee Maintenance Organization Development Maintenance Implementation User Support Communication JMO User Communities Regulatory Authorities Regulated Industries WHO Others
5 How is MedDRA Used? To code (classify) ADR/AEs, history, indication, investigations, procedures, etc. Verbatim/reported information is linked to a MedDRA Lowest Level Term (LLT) LLTs have a parent concept Preferred Term (PT) Grouping terms and System Organ Classes (SOCs) logically group concepts for later retrieval and analysis Used for coding, assessment, and reporting of safety data for both marketed products and clinical studies
6 MedDRA Hierarchy
7 Definition of SMQ Result of cooperative effort between CIOMS and ICH (MSSO) Groupings of terms from one or more MedDRA System Organ Classes (SOCs) related to defined medical condition or area of interest Included terms may relate to signs, symptoms, diagnoses, syndromes, physical findings, laboratory and other physiologic test data, etc., related to medical condition or area of interest Intended to aid in case identification
8 SMQs in Production - Examples As of Version 11.1, a total of 67 in production (Other SMQs in development) Adverse pregnancy outcome/reproductive toxicity (incl neonatal disorders) Agranulocytosis Anaphylactic reaction Cerebrovascular disorders Convulsions Depression and suicide/self-injury Hepatic disorders Ischaemic heart disease Lack of efficacy/effect Peripheral neuropathy Pseudomembranous colitis Rhabdomyolysis/myopathy Severe cutaneous adverse reactions Systemic lupus erythematosus 8
9 MedDRA in Vigibase MSSO has worked with WHO at the Uppsala Monitoring Center to include MedDRA in Vigibase Vigibase includes several million AE cases collected around the world All Vigibase events now have a MedDRA term assigned Vigibase provides searches and reports that support MedDRA Became available in April 2008
10 Chinese MedDRA Current Status Currently conducting the translation Will be maintained like all other translations MSSO will develop a webpage on MSSO website in Chinese to provide basic facts Anticipate initial release in late 2009 Supported by updated MedDRA Desktop Browser Fee to be on a sliding scale
11 CTCAE and MedDRA Common Terminology Criteria for Adverse Events v3.0,required by NCI to code trials Sponsors often code in both CTCAE and MedDRA Current CTCAE/MedDRA mapping insufficient NCI to include MedDRA LLTs directly into CTCAE New version (4.0) will be available in April 2009 Removes need for double coding or map to MedDRA MSSO working closely with NCI and cancer community to develop revision
12 Medical Device Terms CDRH 60 terms already added to MedDRA ISO (TC 210 WG) Coding structure for adverse event type and cause Very general terms MSSO Device Working Group tasks Industry, FDA, JMO Review CDRH and ISO terms Develop recommendations on criteria for inclusion Develop recommendations on the future device hierarchical structure Expected to take 6 months
13 Free MedDRA Training (cont) Training came as a result of concerns from regulatory authorities Poor coding quality Turnover in industry Need to rely on electronic data exchange MSSO is conducting free MedDRA training classes Coding with MedDRA Introduction to MedDRA Data Analysis and SMQs for Physicians Conducted in the US and Europe 35 classes scheduled, 22 completed Free webinars being scheduled
14 Questions? International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
Use of MedDRA in CTCAE and in the Biopharmaceutical Industry
Use of MedDRA in CTCAE and in the Biopharmaceutical Industry Ann Setser, BSN, MEd MedDRA MSSO MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations
Standardised MedDRA Queries (SMQs)
Standardised MedDRA Queries (SMQs) MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).
The Roles of the MSSO and the JMO Mr. Patrick Revelle Director MedDRA Maintenance and Support Services Organization Northrop Grumman
MedDRA 450 Annex 8.5-6 The Roles of the MSSO and the JMO Mr. Patrick Revelle Director MedDRA Maintenance and Support Services Organization Northrop Grumman Mr. Osamu Handa Director Japanese MedDRA Maintenance
Understanding MedDRA The Medical Dictionary for Regulatory Activities
Understanding MedDRA The Medical Dictionary for Regulatory Activities What is ICH? The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human
MedDRA in clinical trials industry perspective
MedDRA in clinical trials industry SFDA ICH MedDRA Workshop, Beijing, 13 14 May 2011 Christina Winter, MD, FFPM Medical director GlaxoSmithKline R&D / ICH MedDRA Management Board 2011 ICH International
MedDRA in pharmacovigilance industry perspective
MedDRA in pharmacovigilance industry SFDA ICH MedDRA Workshop, Beijing, 13 14 May 2011 Christina Winter, MD, FFPM Medical director GlaxoSmithKline R&D / ICH MedDRA Management Board 2011 ICH International
Coding with MedDRA. MedDRA and the MSSO
Coding with MedDRA MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) MedDRA and the MSSO International support and development of
ICD-9-CM to MedDRA Mapping How Well Do the. Disclaimer
ICD-9-CM to MedDRA Mapping How Well Do the Two Terminologies Correlate Anna Zhao-Wong, MD, PhD Deputy Director MedDRA MSSO Disclaimer The views and opinions expressed in the following PowerPoint slides
Classifying Adverse Events From Clinical Trials
Classifying Adverse Events From Clinical Trials Bernard LaSalle, Richard Bradshaw University of Utah, Biomedical Informatics, Salt Lake City, UT USA [email protected] Abstract The use of adverse
Introduction to MedDRA Data Analysis and SMQs for Physicians
Introduction to MedDRA Data Analysis and SMQs for Physicians MedDRA was developed under the auspices of the International ti Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals
A.P. Chen, MD Director, Developmental Therapeutics Clinic Division of Cancer Treatment and Diagnosis National Cancer Institute
A.P. Chen, MD Director, Developmental Therapeutics Clinic Division of Cancer Treatment and Diagnosis National Cancer Institute Click to view Biosketch and Presentation Abstract or page down to review presentation
How to search the EU Clinical Trials Register
28 April 2014 Information and Communications Technology Contents Contents... 1 1. Searching the EU Clinical Trials Register... 1 1.1. Basic search... 2 1.2. Search for multiple words (AND operator)...
Can Coding MedDRA and WHO Drug be as Easy as a Google Search? Sy Truong, Meta-Xceed, Inc., Milpitas, CA Na Li, Pharmacyclics, Sunnyvale CA
Paper 158-2007 Can Coding MedDRA and WHO Drug be as Easy as a Google Search? Sy Truong, Meta-Xceed, Inc., Milpitas, CA Na Li, Pharmacyclics, Sunnyvale CA ABSTRACT In a world where information can easily
Adverse Events in Clinical Trials: Definitions and Documentation
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators Adverse Events in Clinical Trials: Definitions
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled.
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
Risk Management Plan (RMP) Guidance (Draft)
Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Translated by Pharmaceuticals and Medical Devices Agency Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour
EudraVigilance stakeholder change management plan
26 October 2015 EMA/797114/2014 Information Management Division Consultation of Project Maintenance Group 1 15 July 2015 Consultation of Eudravigilance Expert Working Group 23 September 2015 Consultation
EUROPEAN MEDICINES PRACTICES AND TOOLS AGENCY DRUG SAFETY
EUROPEAN MEDICINES AGENCY DRUG SAFETY PRACTICES AND TOOLS Henry Fitt, Kevin Blake, Xavier Kurz Pharmacovigilance & Risk Management European Medicines Agency, London Contents Eudravigilance & Signal Detection
Sonja Brajovic, M.D. Medical Officer, Office of Surveillance and Epidemiology Center for Drug Evaluation and Research Food and Drug Administration
MedDRA Use at FDA ASEAN MedDRA Workshop March 19, 2010 Sonja Brajovic, M.D. Medical Officer, Office of Surveillance and Epidemiology Center for Drug Evaluation and Research Food and Drug Administration
PHV- 4 version 1 ELECTRONIC ADVERSE DRUG REACTION REPORTING
PHV- 4 version 1 ELECTRONIC ADVERSE DRUG REACTION REPORTING This guideline supersedes guideline PHV 4 as of September 16 2008. 1. Introduction and general provisions 1.1 Purpose of the guideline The guideline
Janus Clinical Trials Repository (CTR) An Update
Janus Clinical Trials Repository (CTR) An Update Armando Oliva, M.D. Associate Director for Informatics CDER Office of Computational Science U.S. Food and Drug Administration 2015-03-16 The views expressed
MedDRA 9.1 Review. MedDRA Version Changes - General Remarks. MedDRA 9.1 Changes Overview. MedDRA Version 9.1 Terminology Frequency Distribution
MedDRA 9.1 Review MedDRA Version Changes - General Remarks MedDRA 9.1 Changes Overview MedDRA Version 9.1 Terminology Frequency Distribution MedDRA Changes - General Remarks There are two possible types
Causality Assessment in Practice Pharmaceutical Industry Perspective. Lachlan MacGregor Senior Safety Scientist F. Hoffmann-La Roche Ltd.
Causality Assessment in Practice Pharmaceutical Industry Perspective Lachlan MacGregor Senior Safety Scientist F. Hoffmann-La Roche Ltd., Basel Disclaimer: The opinions expressed in this presentation are
Versioning in Clinical Trials. European Industry MedDRA User Group Meeting March 28 th 2014 Vienna
Versioning in Clinical Trials European Industry MedDRA User Group Meeting March 28 th 2014 Vienna Background MedDRA is updated every 6 months Sometimes, Clinical trials start and end on different versions
Adverse Events: Documenting, Recording, and Reporting
Adverse Events: Documenting, Recording, and Reporting Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Introduction Monitoring of adverse
How To Classify Medical Terms
Introductory Guide MedDRA Version 14.0 Notice to Reader Notice to Reader This Introductory Guide is written in English and is intended only for use with the English version of MedDRA. Additional Introductory
Introductory Guide for Standardised MedDRA Queries (SMQs) Version 15.0
Introductory Guide for Standardised MedDRA Queries (SMQs) Version 15.0 Acknowledgements Acknowledgements MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers
Clinical Trial Protocol Development. Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group
Clinical Trial Protocol Development Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group Objectives The clinical trial protocol is the heart of any
Guidance for Clinical Investigators, Sponsors, and IRBs
Guidance for Clinical Investigators, Sponsors, and IRBs Adverse Event Reporting to IRBs Improving Human Subject Protection U.S. Department of Health and Human Services Office of the Commissioner (OC) Center
MedDRA Coding Basics
MedDRA Coding Basics MedDRA trademark is owned by IFPMA on behalf of ICH MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration
The Role of Patient Advocates and the FDA Deborah J. Miller, Ph.D., M.P.H., R.N. Office of Special Health Issues
The Role of Patient Advocates and the FDA Deborah J. Miller, Ph.D., M.P.H., R.N. Office of Special Health Issues Ovarian Cancer National Alliance 15 th Annual Conference July 16, 2012 Outline Brief history
extended EudraVigilance Medicinal Product Dictionary (XEVMPD) Data-Entry Tool (EVWEB) user manual
extended EudraVigilance Medicinal Product Dictionary (XEVMPD) Data-Entry Tool Version 5.2 7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20
DAIDS Appendix 2 No.: DWD-POL-DM-01.00A2. Data Management Requirements for Central Data Management Facilities
DAIDS Appendix 2 No.: DWD-POL-DM-01.00A2 Data Management Requirements for Central Data Management Facilities The following clinical trial data management requirements must be met in order to ensure the
Good Clinical Practice 101: An Introduction
Good Clinical Practice 101: An Introduction Presented by: Lester Jao Lacorte, MD Medical Officer Commissioner s Fellow Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological
What is Clinical Data Management
What is Clinical Data Management Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection,
Clinical Trials and Safety Surveillance of Drugs in Development
Clinical Trials and Safety Surveillance of Drugs in Development Hoda Eid, M.Sc., Ph.D. Manager, ADR Unit Office of Clinical Trials Therapeutic Products Directorate [email protected] Overview Clinical
Managing & Validating Research Data
Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical
Basics of Clinical Data Management
Biostatistics for Health Care Researchers: A Short Course Basics of Clinical Data Management Presented by: Tim Breen, Ph.D., M.S., C.C.D.M. Division of Biostatistics Indiana University School of Medicine
Coding with Confidence
Coding with Confidence Judy E. Harrison, MD Senior Medical Officer MedDRA MSSO Jean D. Cole, PharmD, CMC Associate Director Gilead Sciences, Inc. Disclaimer The views and opinions expressed in the following
How To Use Sas With A Computer System Knowledge Management (Sas)
Paper AD13 Medical Coding System for Clinical Trials 21 CFR Part 11 Compliant SAS/AF Application Annie Guo, ICON Clinical Research, Redwood City, CA ABSTRACT Medical coding in clinical trials is to classify
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems to support collection, cleaning and management of subject
Needs, Providing Solutions
Identifying Needs, Providing Solutions 1 I n d u s t r y The growth of medical research and the countless innovations coming from the pharmaceutical, biotechnology and medical device industry, has improved
Overview of CDISC Implementation at PMDA. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA)
Overview of CDISC Implementation at PMDA Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA) CDISC 2012 Outline Introduction Update of PMDA activity CDISC implementation
An international approach to the implementation of SNOMED CT and ICPC-2 in Family/General Practice
An international approach to the implementation of SNOMED CT and ICPC-2 in Family/General Practice Nick Booth 1,2, Graeme Miller 1,2,3, Julie O Halloran 1,2,3, John Bennett 4 1 IHTSDO IFP/GP RefSet and
Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management
Written Notice of Participation by the Clinical Data Interchange Standards Consortium (CDISC) and Written Statement for Discussion Topics to be Addressed In the FDA Public Hearing: Electronic Submission
Integrated Clinical Data with Oracle Life Sciences Applications. An Oracle White Paper October 2006
Integrated Clinical Data with Oracle Life Sciences Applications An Oracle White Paper October 2006 Integrated Clinical Data with Oracle Life Sciences Applications EXECUTIVE OVERVIEW Even the largest pharmaceutical
Risk Management in the Pharmaceutical Industry. Elena Apetri, Global Medical Safety Surveillance Schering AG
Risk Management in the Pharmaceutical Industry Elena Apetri, Global Medical Safety Surveillance Schering AG Topics Environment Safety Risk Management Guidance Safety RM Systems Signal detection and evaluation
The Main Challenges around IDMP 1 and Ways to Solve Them. Article by Dieter Schlaps, IT Consulting Life Science, Wessobrunn, Germany
The Main Challenges around IDMP 1 and Ways to Solve Them Article by Dieter Schlaps, IT Consulting Life Science, Wessobrunn, Germany Abstract: As of 1 July 2016, pharmaceutical companies which develop and
Data Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.
Data Management & Case Report Form Development in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 3, 2015 Marge Good, RN, MPH, OCN Nurse Consultant Division of
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. Current Step 4 version
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE THE EXTENT OF POPULATION EXPOSURE TO ASSESS CLINICAL
POST-APPROVAL SAFETY DATA MANAGEMENT: DEFINITIONS AND STANDARDS FOR EXPEDITED REPORTING E2D
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE POST-APPROVAL SAFETY DATA MANAGEMENT: DEFINITIONS
PREP Course #27: Medical Device Clinical Trial Management
PREP Course #27: Medical Device Clinical Trial Management Presented by: Evelyn Huang Jeffrey Revello Office of Research Compliance North Shore-LIJ Health System CME Disclosure Statement The North Shore
History and Principles of Good Clinical Practice
History and Principles of Good Clinical Practice Cristina E. Torres, Ph.D. Social Science Professor, UPM-NIH FERCAP Coordinator ICH: International Conference on Harmonization GCP: Good Clinical Practices
Data Management in Clinical Trials
Data Management in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 19, 2013 Diane St. Germain, RN, MS Nurse Consultant Division of Cancer Prevention National Cancer
Good practice guide on recording, coding, reporting and assessment of medication errors
23 October 2015 EMA/762563/2014 Pharmacovigilance Risk Assessment Committee (PRAC) Good practice guide on recording, coding, reporting and assessment of medication errors Final Draft finalised by Project
INTERIM SITE MONITORING PROCEDURE
INTERIM SITE MONITORING PROCEDURE 1. PURPOSE The purpose of this SOP is to describe the interim monitoring procedures conducted at Institution, according to GCP and other applicable local regulations.
Programme Guide PGDCDM
Post Graduate Diploma in Clinical Data Management and Biostatistics with SAS Programme Guide PGDCDM School of Health Sciences Indira Gandhi National Open University WHY THIS PROGRAMME? The Post Graduate
Introduction to ICD-10-CM. An Introduction to the Transition from ICD-9-CM to ICD-10-CM
Introduction to ICD-10-CM An Introduction to the Transition from ICD-9-CM to ICD-10-CM 1 Purpose Explain why the transition from ICD-9-CM to ICD- 10-CM is needed Describe the differences between ICD-9-CM
REF/2011/06/002450 CTRI Website URL - http://ctri.nic.in
Clinical Trial Details (PDF Generation Date :- Thu, 14 Jul 2016 07:52:01 GMT) CTRI Number Last Modified On 08/07/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
In the second of a quarterly series of articles available to ACDIS members,
Coding Clinic update Conditions documented at the time of discharge, diabetes opportunities highlight important updates for CDI specialists W h i t e p a p e r Editor s note: The following article is provided
Wissenschaftliche Prüfungsarbeit. zur Erlangung des Titels. Master of Drug Regulatory Affairs
TITLE PAGE The new Clinical Trial Regulation and corresponding new EU portal and database: an opportunity to enhance standardisation and interoperability in regulatory systems Wissenschaftliche Prüfungsarbeit
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDELINE ON THE NEED FOR CARCINOGENICITY STUDIES
Introductory Guide MedDRA Version 18.0
Introductory Guide MedDRA Version 18.0 Notice to Reader Notice to Reader This Introductory Guide is written in English and is intended only for use with the English version of MedDRA. Additional Introductory
Guidance for Industry
Guidance for Industry Cancer Drug and Biological Products Clinical Data in Marketing Applications U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and
SNOMED CT. The Language of Electronic Health Records
SNOMED CT The Language of Electronic Health Records Contents SNOMED CT: An overview page 02 What is a Clinical Terminology? What is SNOMED CT? The International Health Terminology Standards Development
ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014
ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014 1. Introduction The St. Michael s Hospital (SMH) REB
GENERAL CONSIDERATIONS FOR CLINICAL TRIALS E8
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GENERAL CONSIDERATIONS FOR CLINICAL TRIALS E8 Current
The European System for Monitoring Drug Safety, EudraVigilance
Paper RC07 The European System for Monitoring Drug Safety, EudraVigilance (Version 1.0) Hans-Georg Wagner, European Medicines Agency, London, UK Olivier Simoen, European Medicines Agency, London, UK Timothy
Oversight of Clinical Trials in Europe - Member State perspective. Gunnar Danielsson Senior Expert Pharmaceutical Inspector
Oversight of Clinical Trials in Europe - Member State perspective Gunnar Danielsson Senior Expert Pharmaceutical Inspector Oversight of Clinical Trials Oversight of clinical trials occur on many different
Overview of Risk Management
Overview of Risk Management Risk Management Plans- An Industry Perspective Dr. Sudhichai Chokekijchai, CSO Novartis (Thailand) Limited (adapted from an RMP training by Dr Judith Sills, Global Head, Medical
CDRH Regulated Software
CDRH Regulated Software An Introduction John F. Murray Jr. CDRH Software Compliance Expert CDRH Regulates Software in the following areas Medical Devices Automation of Production Systems Automation of
Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute
Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute Understand the protocol completely Recognize institutional polices
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency
Medicine Safety Glossary
The following definitions are provided as a resource to supplement the information provided in the Medicine Safety Education section of the Pfizer.com Web site; they are not intended as a comprehensive
Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)
Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Cornelia Kamp, MBA Executive Director Strategic Initiatives Tim Hackett Director
CONDUCTING GLOBAL CLINICAL RESEARCH TRIALS:
CONDUCTING GLOBAL CLINICAL RESEARCH TRIALS: COMPARING AND CONTRASTING FDA MEDICAL DEVICE REGULATIONS FOR CLINICAL INVESTIGATORS WITH ISO 14155:2011 Introduction Today s clinical research landscape for
EHR Archetypes in practice: getting feedback from clinicians and the role of EuroRec
EuroRec - EHTEL Conference, Vienna, October 2007 EHR Archetypes in practice: getting feedback from clinicians and the role of EuroRec Dr Dipak Kalra Centre for Health Informatics and Multiprofessional
Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency
28 August 2015 EMA/386784/2015 Inspections and Human Medicines Pharmacovigilance Division Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the
A clinical research organization
A clinical research organization About Us State of art facility. All clinical trials carried out in accordance with ICH GCP guidelines. Quality services within stipulated time period. Team of experienced
A Phase 2 Study of Interferon Beta-1a (Avonex ) in Ulcerative Colitis
A Phase 2 Study of (Avonex ) in Ulcerative Colitis - Study Results - ClinicalTrials.gov A Phase 2 Study of (Avonex ) in Ulcerative Colitis This study has been completed. Sponsor: Biogen Idec Information
Using CITI Program Content: Good Clinical Practice (GCP)
CONTENT AUTHOR Jaime A. Arango, EdD, CIP CITI Program at the University of Miami INTRODUCTION Like all CITI Program educational materials, the components of the Good Clinical Practice (GCP) series can
Presented by Rosemarie Bell 24 April 2014
Global Good Manufacturing Practice A Comparability Study to Link Good Manufacturing Practice Standards for World Wide Compliance Within the Cellular Therapy Industry Presented by Rosemarie Bell 24 April
Health Products and Food Branch. www.hc-sc.gc.ca
Health Products and Food Branch 1 HEALTH CANADA PART C DIVISION 5 - DRUGS FOR CLINICAL TRIALS INVOLVING HUMAN SUBJECTS Part C - Division 5 2 Part A: Part B: Part C: Part D: Part E: Part G: Part J: Administration
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare
A Guide to Clinical Trials
A Guide to Clinical Trials For young people with cancer and their parents Children s Cancer and Leukaemia Group www.cclg.org.uk Original booklet produced in conjunction with the CCLG Patient Advocacy Committee.
Managing Data in Clinical Research. Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group
Managing Data in Clinical Research Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Clinical data management (CDM) is a multidisciplinary
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE MAINTENANCE OF THE ICH GUIDELINE ON CLINICAL SAFETY
Regulation and Risk Management of Combination Products
Regulation and Risk Management of Combination Products Katherine Ulman Associate Scientist Global Regulatory Compliance Manager Dow Corning Healthcare Jim Curtis Senior Specialist, Healthcare Applications
How to apply for Medical Device License in Taiwan
How to apply for Medical Device License in Taiwan According to Pharmaceutical Affairs Act (PAA), all medical devices regardless their classification shall apply for Medical Device License before they are
Professional Certificate in Primary Care Psychology
Professional Certificate in Primary Care Psychology The NAPPP Primary Care Psychology Certificate training program requires the completion of 10 courses. Each course awards 15 CE credit hours. NAPPP is
General Wellness: Policy for Low Risk Devices. Draft Guidance for Industry and Food and Drug Administration Staff
General Wellness: Policy for Low Risk Devices Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document
Udo Siegmann member of e3c, CDISC Sen. Dir. Acc. Management PAREXEL
Innovative Medicines Technological Platform Udo Siegmann member of e3c, CDISC Sen. Dir. Acc. Management PAREXEL Facts about PAREXEL Full service CRO (Clinical Research Organisation) Involved in more than
Guideline for Industry
Guideline for Industry The Extent of Population Exposure to Assess Clinical Safety: For Drugs Intended for Longterm Treatment of Non-Life- Threatening Conditions ICH-E1A March 1995 GUIDELINE FOR INDUSTRY
